Mesothelioma Cancer Resources Blog
-
Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation
Source: CNNMoney.Com Strativa Pharmaceuticals and Alfacell Corporation have announced that Strativa has acquired the commercialization rights for Alfacell’s mesothelioma drug Onconase. Strativa paid an initial charge of $5 million for the exclusive right to market Onconase in the United States and its territories and will pay up to $30 million for it if FDA approval …
Label: Mesothelioma
Posted on Wednesday, Jan 16, 2008 -
Current State and Future Directions of Pleural Mesothelioma Imaging
Source: Armato III SG, et al., Current state and future directions of pleural mesothelioma imaging, Lung Cancer (2007), doi:10.1016/j.lungcan.2007.09.027 Imaging is one of the most important aspects of cancer diagnostics. It allows the physician team to look at—and respond to—a number of different aspects of a person’s disease, including tumor extent, invasion of distant body …
Label: Mesothelioma
Posted on Wednesday, Jan 16, 2008 -
Endoscopic Ultrasound-Guided Fine Needle Aspiration is Useful for Nodal Staging in Patients with Pleural Mesothelioma
Source: Endoscopic ultrasound-guided fine needle aspiration is useful for nodal staging in patients with pleural mesothelioma (Diagn Cytopathol. 2008 Jan;36(1):32-7) Effective surgical management of mesothelioma requires the identification of the extent of actual tumor mass, as well as the identification of the malignant status of a patient’s lymph nodes. The former is important so the …
Label: Mesothelioma
Posted on Monday, Jan 14, 2008
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.